Sonoma BioTherapeutics

Biotechnology

South San Francisco, California, United States

United States

Sonoma BioTherapeutics seattle-based company leading the development of adoptive Treg therapies cell for autoimmune.

Employee 01 to 10 people

Early Stage Venture stage company

Last raised $265,000,000 in August 2021